Navigation Links
Cellular Protein Yields Clues to Diabetes, Alzheimer's
Date:7/22/2009

Animal tests suggest humanin could have therapeutic benefits

WEDNESDAY, July 22 (HealthDay News) -- New information about a cellular protein might help in efforts to develop drug treatments for diabetes and Alzheimer's disease, researchers say.

In tests on rats, they found that humanin, which may prevent nerve cells from dying, also helps improve insulin action and lower blood glucose levels.

"This new role of humanin in glucose metabolism, in addition to its role in Alzheimer's disease, is very intriguing since scientists have long proposed a link between type 2 diabetes and Alzheimer's disease," Dr. Nir Barzilai, a professor and director of the Institute for Aging Research at the Albert Einstein College of Medicine in New York City, said in a news release from the college.

"Humanin could turn out to be a therapeutic option for two common debilitating diseases that affect millions of people, Barzilai said. "Additionally, humanin may help treat other age-related diseases."

The study appears online July 22 in PLoS One.

More information

The U.S. National Institute on Aging has more about Alzheimer's disease.



-- Robert Preidt



SOURCE: Albert Einstein College of Medicine, news release, July 21, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Story ideas from molecular & cellular proteomics
2. A Chinese medicine compound has satisfactory anti-cancer effects on hepatocellular carcinoma
3. ReCellular Named Exclusive Cell Phone Recycling Partner for Consumer Cellular
4. Intra-arterial combination chemotherapy induces long-term survival for hepatocellular carcinoma
5. A new chemotherapeutic target for hepatocellular carcinoma
6. Helicobacter pylori inhibits intercellular communication of cultured gastric cells
7. UC Davis researchers identify a cellular pathway that makes prostate cancer fatal
8. Cellular Disorder Might Influence Behavior
9. Extracellular protein sensitizes ovarian cancer cells to chemotherapy
10. Protein-dependent switch regulates intracellular trafficking in epithelial cells
11. St. Jude Finds Link Between Cellular Defense Processes, Showing How Cancer Cells Survive
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cellular Protein Yields Clues to Diabetes, Alzheimer's
(Date:6/23/2017)... ... June 23, 2017 , ... Radabaugh & Associates, a locally ... business owners in North Central West Virginia, is embarking on a cooperative charity ... residents in the region. , The Stepping Stones organization offers a series of ...
(Date:6/22/2017)... ... 2017 , ... Plastic Surgery Associates is proud to report that founding surgeon, ... research and information firm, Castle Connolly, releases their list of the most notable and ... 3rd time that Dr. Canales has been recognized by Castle Connolly. , ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... from the American Heart Association (AHA) to launch a Rheumatic Heart Disease Center, ... prevention and diagnosis of rheumatic heart disease (RHD) in high-risk, financially disadvantaged countries ...
(Date:6/22/2017)... , ... June 22, 2017 , ... ... announced today that it has received certification for ANSI/ASIS PSC.1-2012. The company’s work ... in environments where the rule of law has been degraded. The PSC.1 standard ...
(Date:6/20/2017)... ... June 20, 2017 , ... TwelveStone Health Partners, ... a Nashville-based private equity firm, has invested $3.35 million in the company. ... and Claritas Capital offers the smart money, speed to market and accountability we ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... -- Endo International plc (NASDAQ: ENDP ) ... Joseph R. Goodwin , U.S. District Court Judge for ... , entered a case management order in MDL 2325, ... Litigation (the "MDL") that includes a provision requiring plaintiffs ... on specific causation within one hundred twenty (120) days ...
(Date:6/3/2017)... 2017  Eli Lilly and Company (NYSE: ... the Phase 3 MONARCH 2 study showed that ... in combination with fulvestrant, significantly improved progression-free survival ... women with hormone-receptor-positive (HR+), human epidermal growth factor ... relapsed or progressed after endocrine therapy (median PFS, ...
(Date:5/30/2017)... AVIV, Israel , May 30, 2017 ... stage pharmaceutical Company specializing in the development of ... will present a company overview at three upcoming ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: